Search hospitals > Alberta > EDMONTON
Cross Cancer Institute
Claim this profileEDMONTON, Alberta T6G 1Z2
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Prostate Cancer
Conducts research for Non-Small Cell Lung Cancer
739 reported clinical trials
34 medical researchers
Summary
Cross Cancer Institute is a medical facility located in EDMONTON, Alberta. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Non-Small Cell Lung Cancer and other specialties. Cross Cancer Institute is involved with conducting 739 clinical trials across 387 conditions. There are 34 research doctors associated with this hospital, such as Quincy Chu, Michael Chu, MD, Michael Kolinsky, and Samir I. Patel.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
Stage III
HER2 negative
Top PIs
Quincy ChuCross Cancer Institute8 years of reported clinical research
Studies Tumors
Studies Cancer
17 reported clinical trials
48 drugs studied
Michael Chu, MDLondon Health Sciences Centre3 years of reported clinical research
Studies Coronary Artery Disease
Studies Stroke
17 reported clinical trials
26 drugs studied
Michael KolinskyCross Cancer Institute3 years of reported clinical research
Studies Prostate Cancer
Studies Endometrial Cancer
6 reported clinical trials
20 drugs studied
Samir I. PatelCross Cancer Institute2 years of reported clinical research
Studies Brain Tumor
Studies Cancer
5 reported clinical trials
11 drugs studied
Clinical Trials running at Cross Cancer Institute
Breast Cancer
Cancer
Non-Small Cell Lung Cancer
Tumors
Solid Tumors
Multiple Myeloma
Colorectal Cancer
Lymphoma
Plasma Cell Neoplasms
Lung Cancer
Sacituzumab Govitecan
for Triple-Negative Breast Cancer
This trial is testing a drug called sacituzumab govitecan-hziy, which targets and kills cancer cells. It focuses on patients with advanced triple-negative breast cancer who have limited treatment options. The drug works by attaching to cancer cells and releasing a substance that kills them. Sacituzumab govitecan-hziy is an FDA-approved treatment for metastatic triple-negative breast cancer, especially for patients who have already tried other treatments.
Recruiting4 awards Phase 3
Sacituzumab Govitecan + Pembrolizumab
for Triple-Negative Breast Cancer
This trial compares the effectiveness of a combination of two drugs, SG and pembrolizumab, in patients with advanced triple-negative breast cancer. SG targets and kills cancer cells with chemotherapy, while pembrolizumab helps the immune system attack the cancer. Pembrolizumab has been shown to improve survival in various cancers, including triple-negative breast cancer, when used alone or in combination with other treatments.
Recruiting4 awards Phase 3
ARV-471
for Breast Cancer
This trial tests a new oral medicine, ARV-471, against an existing injectable treatment, fulvestrant, in people with advanced breast cancer that has spread. Both medicines aim to slow cancer growth by targeting estrogen receptors. ARV-471 is developed as an oral alternative to fulvestrant.
Recruiting2 awards Phase 35 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Cross Cancer Institute?
Cross Cancer Institute is a medical facility located in EDMONTON, Alberta. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Non-Small Cell Lung Cancer and other specialties. Cross Cancer Institute is involved with conducting 739 clinical trials across 387 conditions. There are 34 research doctors associated with this hospital, such as Quincy Chu, Michael Chu, MD, Michael Kolinsky, and Samir I. Patel.
Where is Cross Cancer Institute located?
The Cross Cancer Institute is situated at 11560 University Avenue NW, Edmonton, Alberta, T6G 1Z2. It is accessible by car, with real-time driving directions available to account for traffic and road conditions. For those preferring public transportation, bus and light rail stations are located at 117 Street & University Avenue and 114 Street & 83 Avenue.
Who should I call to ask about financial aid or insurance network?
**Cross Cancer Institute Financial Assistance and Insurance Information:**
- **Memorial Sloan Kettering Cancer Center:** For insurance inquiries, contact 646-497-9176, Monday through Friday.
- **Northwell Health:** Offers a financial assistance program for those uninsured or underinsured. Eligibility is based on family size and income, determined through an application process.
- **Roswell Park Comprehensive Cancer Center:** Provides financial assistance for New York State residents who are uninsured or struggling with out-of-pocket costs. Contact financial counselors at 716-845-4782.
- **NYU Langone Health:** Financial assistance available for patients without insurance or with partial insurance coverage. Apply through the financial assistance application and consult a financial counselor at any listed location.
What insurance does Cross Cancer Institute accept?
For information on insurance plans accepted by the Cross Cancer Institute in Alberta, Canada, please contact the institute directly.
What awards or recognition has Cross Cancer Institute received?
The Cross Cancer Institute, located in Edmonton, Alberta, is renowned for its comprehensive healthcare services for cancer patients. It has been awarded $5 million by the Alberta Cancer Foundation to fund innovative cancer research projects, underscoring its dedication to improving cancer care and treatment.